IP Library Granted Patent US 7,190,109
Granted Patent B2
US 7,190,109 · App. 10/755,318 · Granted Mar 13, 2007

Illuminator for photodynamic therapy

Assignee: Dusa Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,190,109
App. No.
10/755,318
Granted
Mar 13, 2007
Kind
B2
Abstract

An apparatus and method for photodynamic therapy or photodynamic diagnosis using an illuminator comprising a plurality of light sources generally conforming to a contoured surface and irradiating the contoured surface with substantially uniform intensity visible light. The light sources may comprise generally U-shaped fluorescent tubes that are driven by electronic ballasts. Adjustment of the ballast voltage controls the output power of the tubes. The tubes are supported by a sheet-metal or plastic housing and are covered by a polycarbonate shield which directs cooling airflow within the unit and prevents glass-patient contact in the event of tube breakage. An aluminum reflector located behind the tubes increases both the output irradiance and the uniformity of the output distribution. The spacing of the U-shaped tubes is varied to increase the output at the edges of the illuminator to make the output more uniform. Also, different portions of the tubes are cooled at different amounts, to improve uniformity. A light sensor monitors output from the U-shaped tubes to provide a signal for adjusting the output from the tubes.

Claims (20)

1. An illuminator for treating or diagnosing a patient, comprising:

at least one light source, comprising a phosphor which emits light in the blue region, configured to illuminate the patient to treat or diagnose a dermatological condition, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

2. An illuminator as set forth in claim 1 , wherein the at least one light source has a peak wavelength near 417 nm.

3. An illuminator as set forth in claim 1 , wherein the light source comprises a fluorescent lamp.

4. An illuminator for treating or diagnosing a patient, comprising:

at least one light source, comprising a phosphor which emits light in the blue region, configured to illuminate the patient to treat or diagnose a dermatological condition, wherein the light is substantially entirely limited to the blue region of the spectrum, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

5. An illuminator as set forth in claim 4 , wherein the at least one light source has a peak wavelength near 417 nm.

6. An ilhuninator as set forth in claim 4 , wherein the light source comprises a fluorescent lamp.

7. An illuminator for treating or diagnosing a patient, comprising:

at least one light source, comprising a Europium doped phosphor, configured to illuminate the patient to treat or diagnose a dermatological condition, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

8. An illuminator as set forth in claim 7 , wherein the Europium doped phosphor comprises a Europium doped Strontium phosphate.

9. An illuminator as set forth in claim 7 , wherein the Europium doped phosphor comprises Sr 2 P 2 O 7 :Eu.

10. An illuminator as set forth in claim 7 , wherein the at least one light source has a peak wavelength near 417 nm.

11. An illuminator as set forth in claim 7 , wherein the light source comprises a fluorescent lamp.

12. An illuminator for treating or diagnosing a patient, comprising:

at least one light source, comprising a Europium doped phosphor; configured to illuminate the patient to treat or diagnose a dermatological condition,

wherein the light source is configured to illuminate the patient with substantially uniform intensity blue light, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

13. An illuminator for treating or diagnosing a patient, comprising:

at least one light source, comprising a Europium doped phosphor, configured to illuminate the patient to treat or diagnose a dermatological condition,

wherein at least part of the at least one light source is a curved tube, wherein the spectral output of the at least one light source substantially matches the absorption spectrum of protoporphyrin IX.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2012
From: LUNDAHL, SCOTT; KOZODOY, REBECCA; CARROLL, RONALD; LEPPELMEIER, ELTON
To: DUSA PHARMACEUTICALS INC.
Reel/Frame 029034/0214 →
Continuity (3)
Division 0977408400 · Jan 31, 2001
Division 0907077200 · May 1, 1998
Related Publication 20040143308A1 · Jul 22, 2004